Status:
COMPLETED
CompuFlo Thoracic Epidural Study
Lead Sponsor:
YATISH SIDDAPURA RANGANATH
Conditions:
Thoracic Epidural Anesthesia
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Traditionally, loss-of-resistance (LOR) to air or saline with a special ground-glass syringe is the technique used to identify epidural space, but failure rates up to 30% have been reported using this...
Detailed Description
Traditional technique vs CompuFlo use: Using the traditional technique (loss-of-resistance technique), the epidural needle is advanced through the subcutaneous tissues with the needle stylet in place ...
Eligibility Criteria
Inclusion
- Age: 18 to 70
- BMI: 18 to 50 kg/m2
- Require pain control for major thoracic or abdominal surgeries
- Require pain control for rib fractures
- English is the subject's first language
- Must be able to signed informed consent
Exclusion
- Age: Less than 18 and older than 70
- Must be free of significant valvular heart disease
- Pregnant women
- Prisoners
- Contraindication to thoracic epidural anesthesia
- Allergy or hypersensitivity to local anesthetics
- Unable to provide written informed consent
Key Trial Info
Start Date :
March 26 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2022
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT03826186
Start Date
March 26 2019
End Date
June 1 2022
Last Update
October 19 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States, 52242